SLC3037
Product Specifications
Target
MAPK, NOD-like Receptor (NLR)
Related Pathways
MAPK, Immunology/Inflammation
Bioactivity
SLC3037 is an NLRP3 inhibitor that prevents the binding or oligomerization of NLRP3 with NEK7, thereby inhibiting inflammasome activation triggered by MSU and other activators. It is suitable for research related to gout, cardiovascular diseases, metabolic syndrome, or neurodegenerative diseases.
Molecular Formula
C29H35N7OS
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
